Equities research analysts expect that Align Technology, Inc. (NASDAQ:ALGN) will post $408.25 million in sales for the current quarter, Zacks Investment Research reports. Seven analysts have provided estimates for Align Technology’s earnings. The lowest sales estimate is $405.10 million and the highest is $409.44 million. Align Technology reported sales of $310.34 million in the same quarter last year, which indicates a positive year over year growth rate of 31.5%. The firm is scheduled to announce its next quarterly earnings results on Thursday, April 26th.
According to Zacks, analysts expect that Align Technology will report full year sales of $408.25 million for the current financial year, with estimates ranging from $1.81 billion to $1.93 billion. For the next fiscal year, analysts expect that the business will report sales of $2.24 billion per share, with estimates ranging from $2.10 billion to $2.35 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that follow Align Technology.
Align Technology (NASDAQ:ALGN) last posted its quarterly earnings data on Tuesday, January 30th. The medical equipment provider reported $1.19 earnings per share for the quarter, beating analysts’ consensus estimates of $0.96 by $0.23. The company had revenue of $421.30 million during the quarter, compared to analysts’ expectations of $395.88 million. Align Technology had a net margin of 15.71% and a return on equity of 28.55%. The firm’s revenue for the quarter was up 43.7% on a year-over-year basis. During the same period in the prior year, the company posted $0.59 EPS.
In other Align Technology news, VP Julie Tay sold 3,500 shares of the firm’s stock in a transaction dated Monday, November 13th. The shares were sold at an average price of $253.00, for a total value of $885,500.00. Following the transaction, the vice president now owns 12,213 shares of the company’s stock, valued at $3,089,889. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Emory Wright sold 45,780 shares of the firm’s stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $260.08, for a total transaction of $11,906,462.40. Following the completion of the transaction, the vice president now directly owns 29,957 shares in the company, valued at approximately $7,791,216.56. The disclosure for this sale can be found here. Insiders sold 85,529 shares of company stock worth $22,254,743 in the last three months. 1.60% of the stock is currently owned by corporate insiders.
Large investors have recently made changes to their positions in the business. USA Mutuals Advisors Inc. acquired a new stake in shares of Align Technology in the fourth quarter valued at approximately $101,000. Whittier Trust Co. acquired a new stake in shares of Align Technology in the third quarter valued at approximately $107,000. Whittier Trust Co. of Nevada Inc. increased its stake in shares of Align Technology by 166.7% in the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 504 shares of the medical equipment provider’s stock valued at $112,000 after purchasing an additional 315 shares during the period. Meritage Portfolio Management acquired a new stake in shares of Align Technology in the fourth quarter valued at approximately $201,000. Finally, Coldstream Capital Management Inc. acquired a new stake in shares of Align Technology in the second quarter valued at approximately $202,000. Institutional investors own 82.50% of the company’s stock.
Align Technology (NASDAQ:ALGN) opened at $234.33 on Thursday. Align Technology has a 12-month low of $92.61 and a 12-month high of $287.32. The company has a market cap of $19,358.90, a PE ratio of 82.51, a PEG ratio of 1.84 and a beta of 1.48.
COPYRIGHT VIOLATION WARNING: This article was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://www.americanbankingnews.com/2018/02/08/408-25-million-in-sales-expected-for-align-technology-inc-algn-this-quarter.html.
About Align Technology
Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.